Journal of Preventive Medicine and Public Health

  • 제40권2호
  • /
  • Pages.122-129
  • /
  • 2007
  • /
  • 1975-8375(pISSN)
  • /
  • 2233-4521(eISSN)
대한예방의학회 (The Korean Society for Preventive Medicine)
권호 표지

유전체 코호트 연구의 윤리적 고려 사항

Ethical Considerations in Genomic Cohort Study

  • 최은경 (서울대학교 의과대학 의사학교실) ;
  • 김옥주 (서울대학교 의과대학 의사학교실)
  • Choi, Eun-Kyung (Department of History of Medicine and Medical Humanities, College of Medicine Seoul National University) ;
  • Kim, Ock-Joo (Department of History of Medicine and Medical Humanities, College of Medicine Seoul National University)
  • 발행 : 2007.03.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

During the last decade, genomic cohort study has been developed in many countries by linking health data and genetic data in stored samples. Genomic cohort study is expected to find key genetic components that contribute to common diseases, thereby promising great advance in genome medicine. While many countries endeavor to build biobank systems, biobank-based genome research has raised important ethical concerns including genetic privacy, confidentiality, discrimination, and informed consent. Informed consent for biobank poses an important question: whether true informed consent is possible in population-based genomic cohort research where the nature of future studies is unforeseeable when consent is obtained. Due to the sensitive character of genetic information, protecting privacy and keeping confidentiality become important topics. To minimize ethical problems and achieve scientific goals to its maximum degree, each country strives to build population-based genomic cohort research project, by organizing public consultation, trying public and expert consensus in research, and providing safeguards to protect privacy and confidentiality.

키워드

참고문헌

  1. Kang DH, Lee KM. Current status of genomic epidemiology research. Korean J Prev Med 2003; 36(3): 213-222 (Korean)
  2. Beskow LM, Burke W, Merz JF, Barr PA, Terry S, Penchaszadeh VB, Gostin LO, Gwinn M, Khoury MJ. Informed consent for population-based research involving genetics. JAMA 2001; 286(18): 2315-2321 https://doi.org/10.1001/jama.286.18.2315
  3. Clayton EW, Steinberg KK, Khoury MJ, Thomson E, Andrews L, Kahn MJ, Kopelman LM, Weiss JO. Informed consent for genetic research on stored tissue samples. JAMA 1995; 274(22): 1786-1792 https://doi.org/10.1001/jama.274.22.1786
  4. Wertz DC. Archived specimens: A platform for discussion. Community Genet 1999; 2(2-3): 51-60 https://doi.org/10.1159/000016187
  5. Hong YC, Lee KH. Specimen storage and analysis for genomic epidemiology. Korean J Prev Med 2003; 36(3): 209-221 (Korean)
  6. Austin MA, Harding S, McElroy C. Genebanks: A comparison of eight proposed international genetic databases. Community Genet 2003; 6(1): 37-45 https://doi.org/10.1159/000069544
  7. CIOMS. Special Ethical Considerations for Epidemiological Research. 2006 [cited 2007 Feb 27]; Available from: URL:http://www.cioms.ch/special_ethical_consideration.pdf
  8. SACGHS. Policy Issues Associated with Undertaking a Large U.S. Population Cohort Project on Genes, Environment, and Disease. 2006
  9. Caulfield T, Upshur RE, Daar A. DNA databanks and consent: A suggested policy option involving an authorization model. BMC Med Ethics 2003; 4: E1 https://doi.org/10.1186/1472-6939-4-1
  10. Williams G, Schroeder D. Human genetic banking: altruism, benefit and consent. New Genet Soc 2004; 23(1): 89-103 https://doi.org/10.1080/1463677042000189598
  11. Clayton EW. Informed consent and biobanks. J Law Med Ethics 2005; 33(1): 15-21 https://doi.org/10.1111/j.1748-720X.2005.tb00206.x
  12. Beskow LM. Ethical, Legal and Social Issues in the Design and Conduct of Human Genome Epidemiology Studies. In: Khoury MJ, Little J, Burke W, Editors. Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease. New York: Oxford University Press; 2004. p. 58-76
  13. Hansson MG, Dillner J, Bartram CR, Carlson JA, Helgesson G. Should donors be allowed to give broad consent to future biobank research? Lancet Oncol 2006; 7(3): 266-269 https://doi.org/10.1016/S1470-2045(06)70618-0
  14. Summary of the Official Norwegian Report NOU 2005:1-Good Research, Better Health [cited 2007 Feb 27]; Available from: URL: http://www.helsetilsynet.no/upload/english/nou_2005_1_english%20summary.pdf
  15. National Bioethics Advisory Commission. Research Involving Human Biological Materials: Ethical Issues and Policy Guidance, Vol. 1. Rockville, MD: National Bioethics Advisory Commission; 1999. p. 55-76
  16. HUGO Ethics Committee. Statement on DNA sampling: Control and access. 1998 [cited 2007 Feb 27]; Available from: URL:http://www.hugo-international.org/Statement_on_DNA_Sampling.html
  17. Kaye J. Abandoning Informed Consent: The Case of Genetic Research in Population Collections. In: Corrigan O, Tutton R. Editors. Genetic Databases: Socio-ethical Issues in the Collection and Use of DNA London, New York: Routledge; 2004. p. 117-138
  18. UK Biobank. Ethics and Governance Framework ver 2. 2006 [cited 2007 Feb 27]; Available from: URL:http://www.ukbiobank.ac.uk/docs/EGF_Version2_July%202006.pdf
  19. Korea. Bioetics and Biosafety Act. 2005 (Korean)
  20. United Nations Educational, Scientific, and Cultural Organization(UNESCO). Human Genetic Data: Preliminary Study by the IBC on its Collection, Processing, Storage and Use. 2002 [cited 2007 Feb 27]; Available from: URL: http://portal.unesco.org/shs/en/ev.php-URL_ID=2138&URL_DO=DO_TOPIC&URL_SECTION=201.html
  21. HUGO Ethics Committee. Statement on DNA sampling: control and access. London. 1998 [cited 2007 Feb 27]; Available from: URL: http://www.hugo-international.org/Statement_on_DNA_Sampling.html
  22. Buchanan A. An ethical framework for biological samples policy. In: National Bioethics Advisory Committee, editors. Research Involving Human Biological Materials: Ethical Issues and Policy Guidance, Vol II. Rockville, MD: National Bioethics Advisory Commission; 2000. p. B-1-B-35
  23. Knoppers BM. Biobanking: international norms. J Law Med Ethics 2005; 33(1): 7-14 https://doi.org/10.1111/j.1748-720X.2005.tb00205.x
  24. Office for Human Research Protections (OHRP), Department of Health and Human Services (HHS). Guidance on Research Involving Coded Private Information or Biological Specimens [cited 2007 Feb 27]; Available from: URL:http://www.hhs.gov/ohrp/humansubjects/guidance/cdebiol.pdf
  25. HUGO Intellectual Property Committee. Statement on Patenting on Patenting Issues Related To Early Release of Sequence Data. 1997[cited 2007 Feb 27]; Available from: URL:http://www.hugo-international.org/PDFs/Statement%20on%20Patenting%20Issues%20Relating%20to%20Raw%20Sequence%20Dat.pdf
  26. Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: Convention on human rights and biomedicine. Council of Europe Convention of Biomedicine. Hum Reprod 1997; 12(9): 2076-2080 https://doi.org/10.1093/humrep/12.9.2076
  27. HUGO Ethics Committee. Statement on Benefit-Sharing. 2000 [cited 2007 Feb 27]; Available from: URL:http://www.hugo-international.org/Statement_on_Benefit_Sharing.htm
  28. Mannvernd. A Landmark Decision by the Icelandic Supreme Court. 2004 [cited 2007 Feb 27]; Available from: URL:http://www.mannvernd.is/english/lawsuits/Mannvernd_PressRelease_SupremeCourt.pdf
  29. Estonian Genome Project [cited 2007 Feb 27]; Available from: URL:http://www.geenivaramu.ee
  30. UK Biobank. The UK Biobank Ethics and Governance Framework. 2004 [cited 2007 Feb 27]; Available from: URL:http://www.ukbiobank.ac.uk/docs/egf-summary.doc
  31. Human Genetics Commission. Inside Information: Balancing Interests in the Use of Personal Genetic Data. London.: 2002 [cited 2007 Feb 27]; Available from: URL:http://www.hgc.gov.uk/UploadDocs/DocPub/Document/insideinformation_summary.pdf
  32. CARTaGENE [cited 2007 Feb 27]; Available from: URL:http://www.cartagene.qc.ca